Brief: First Tracks Biotherapeutics, The Planned Spin-Off Of Anaptys, Secures Commitments Of $145 Million In Private Placement
27/03/2026 13:03
AnaptysBio Inc ANAB.O: FIRST TRACKS BIOTHERAPEUTICS, THE PLANNED SPIN-OFF OF ANAPTYS, SECURES COMMITMENTS OF $145 MILLION IN PRIVATE PLACEMENT Source text: ID:nGNX1Ml9sl Further company coverage: ANAB.O
Recent news on AnaptysBio
See all newsU.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
AnaptysBio's Q1 collaboration revenue falls, net loss widens
Brief: AnaptysBio Q1 Net Income USD -52.884 Million
Brief: Anaptys Appoints Chris Murphy As Chief Financial Officer And Owen Hughes To Board Of Directors
Brief: GSK Says Unit Tesaro's Claim For Declaratory Judgment Against Anaptysbio Unchanged